Advertisement

Topics

Johnson & Johnson and CSIR-IMTECH partner to discover new tuberculosis treatments

19:00 EDT 16 Aug 2017 | Pharmaceutical Technology

Johnson & Johnson’s India-based business has signed a memorandum of understanding (MoU) with the Institute of Microbial Technology (IMTECH) to discover and develop new treatments for tuberculosis (TB).

Original Article: Johnson & Johnson and CSIR-IMTECH partner to discover new tuberculosis treatments

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson and CSIR-IMTECH partner to discover new tuberculosis treatments"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...